Andrew Donkor1,2, Vivian Della Atuwo-Ampoh3, Craig Opie4, Frederick Yakanu2, Dorothy Lombe5, Jamal Khader6. 1. Faculty of Health, University of Technology Sydney, IMPACCT, (Improving Palliative, Aged and Chronic Care through Clinical Research and Translation), NSW Australia. 2. Korle-Bu Teaching Hospital, National Centre for Radiotherapy and Nuclear Medicine, Accra, Ghana. 3. Department of Medical Imaging, School of Allied Health Sciences, University of Health and Allied Sciences, Ghana. 4. Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia. 5. Cancer Diseases Hospital, Zambia. 6. King Hussein Cancer Center, Amman, Jordan.
Abstract
BACKGROUND: The aim of the study was to identify strategies adopted by radiotherapy centres in low- and middle-income countries (LMICs) to mitigate the effects of COVID-19. Studies summarising COVID-19 mitigation strategies designed and implemented by radiotherapy centres in LMICs to avoid delays, deferrments and interruptions of radiotherapy services are lacking. MATERIALS AND METHODS: A systematic review was conducted and reported in accordance with the preferred reporting items for systematic review and meta-analysis guideline. Ovid Embase, Ovid MEDLINE and CINAHL were searched for peer-reviewed articles that reported measures adopted by radiotherapy centres in LMICs to reduce the risk of COVID-19. Information on different strategies were extracted from the included studies and textual narrative synthesis was conducted. RESULTS: Of 60 articles retrieved, eleven were included. Majority of the studies were conducted in China. Ten of the included studies employed a qualitative design. Four themes were identified: preparing and equipping staff; reinforcing infection prevention and control policies; strengthening coordination and communication; and maintaining physical distancing. Studies reported that radiotherapy centres had: formed COVID-19 response multidisciplinary team; maximised the use of telehealth; adjusted the layout of waiting areas; divided staff into teams; dedicated a room for isolating suspected cases; and adopted triage systems. CONCLUSIONS: Local adaptation of established global strategies coupled with timely development of guidelines, flexibility and innovation have allowed radiotherapy leaders to continue to deliver radiotherapy services to cancer patients in LMICs during the COVID-19 crisis. Robust data collection must be encouraged in LMICs to provide an evidence-based knowledge for use in the event of another pandemic.
BACKGROUND: The aim of the study was to identify strategies adopted by radiotherapy centres in low- and middle-income countries (LMICs) to mitigate the effects of COVID-19. Studies summarising COVID-19 mitigation strategies designed and implemented by radiotherapy centres in LMICs to avoid delays, deferrments and interruptions of radiotherapy services are lacking. MATERIALS AND METHODS: A systematic review was conducted and reported in accordance with the preferred reporting items for systematic review and meta-analysis guideline. Ovid Embase, Ovid MEDLINE and CINAHL were searched for peer-reviewed articles that reported measures adopted by radiotherapy centres in LMICs to reduce the risk of COVID-19. Information on different strategies were extracted from the included studies and textual narrative synthesis was conducted. RESULTS: Of 60 articles retrieved, eleven were included. Majority of the studies were conducted in China. Ten of the included studies employed a qualitative design. Four themes were identified: preparing and equipping staff; reinforcing infection prevention and control policies; strengthening coordination and communication; and maintaining physical distancing. Studies reported that radiotherapy centres had: formed COVID-19 response multidisciplinary team; maximised the use of telehealth; adjusted the layout of waiting areas; divided staff into teams; dedicated a room for isolating suspected cases; and adopted triage systems. CONCLUSIONS: Local adaptation of established global strategies coupled with timely development of guidelines, flexibility and innovation have allowed radiotherapy leaders to continue to deliver radiotherapy services to cancer patients in LMICs during the COVID-19 crisis. Robust data collection must be encouraged in LMICs to provide an evidence-based knowledge for use in the event of another pandemic.
Authors: Kamal S Saini; Begoña de Las Heras; Javier de Castro; Ramachandran Venkitaraman; Martine Poelman; Gopalakrishnan Srinivasan; Monika Lamba Saini; Sanjeev Verma; Manuela Leone; Philippe Aftimos; Giuseppe Curigliano Journal: Lancet Haematol Date: 2020-04-24 Impact factor: 18.959